• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于深度神经网络的结直肠癌与腺瘤发病和死亡(CRC-AIM)微观模拟模型的校准和验证。

Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks.

机构信息

Health Economics and Outcome Research, Exact Sciences Corporation, Madison, WI, USA.

Departments of Industrial & Systems Engineering and Population Health Sciences, University of Wisconsin-Madison, Madison, WI, USA.

出版信息

Med Decis Making. 2023 Aug;43(6):719-736. doi: 10.1177/0272989X231184175. Epub 2023 Jul 11.

DOI:10.1177/0272989X231184175
PMID:37434445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10422851/
Abstract

OBJECTIVES

Machine learning (ML)-based emulators improve the calibration of decision-analytical models, but their performance in complex microsimulation models is yet to be determined.

METHODS

We demonstrated the use of an ML-based emulator with the Colorectal Cancer (CRC)-Adenoma Incidence and Mortality (CRC-AIM) model, which includes 23 unknown natural history input parameters to replicate the CRC epidemiology in the United States. We first generated 15,000 input combinations and ran the CRC-AIM model to evaluate CRC incidence, adenoma size distribution, and the percentage of small adenoma detected by colonoscopy. We then used this data set to train several ML algorithms, including deep neural network (DNN), random forest, and several gradient boosting variants (i.e., XGBoost, LightGBM, CatBoost) and compared their performance. We evaluated 10 million potential input combinations using the selected emulator and examined input combinations that best estimated observed calibration targets. Furthermore, we cross-validated outcomes generated by the CRC-AIM model with those made by CISNET models. The calibrated CRC-AIM model was externally validated using the United Kingdom Flexible Sigmoidoscopy Screening Trial (UKFSST).

RESULTS

The DNN with proper preprocessing outperformed other tested ML algorithms and successfully predicted all 8 outcomes for different input combinations. It took 473 s for the trained DNN to predict outcomes for 10 million inputs, which would have required 190 CPU-years without our DNN. The overall calibration process took 104 CPU-days, which included building the data set, training, selecting, and hyperparameter tuning of the ML algorithms. While 7 input combinations had acceptable fit to the targets, a combination that best fits all outcomes was selected as the best vector. Almost all of the predictions made by the best vector laid within those from the CISNET models, demonstrating CRC-AIM's cross-model validity. Similarly, CRC-AIM accurately predicted the hazard ratios of CRC incidence and mortality as reported by UKFSST, demonstrating its external validity. Examination of the impact of calibration targets suggested that the selection of the calibration target had a substantial impact on model outcomes in terms of life-year gains with screening.

CONCLUSIONS

Emulators such as a DNN that is meticulously selected and trained can substantially reduce the computational burden of calibrating complex microsimulation models.

HIGHLIGHTS

Calibrating a microsimulation model, a process to find unobservable parameters so that the model fits observed data, is computationally complex.We used a deep neural network model, a popular machine learning algorithm, to calibrate the Colorectal Cancer Adenoma Incidence and Mortality (CRC-AIM) model.We demonstrated that our approach provides an efficient and accurate method to significantly speed up calibration in microsimulation models.The calibration process successfully provided cross-model validation of CRC-AIM against 3 established CISNET models and also externally validated against a randomized controlled trial.

摘要

目的

基于机器学习(ML)的仿真器可改善决策分析模型的校准,但它们在复杂的微观模拟模型中的性能仍有待确定。

方法

我们展示了如何在 Colorectal Cancer (CRC)-Adenoma Incidence and Mortality (CRC-AIM) 模型中使用基于 ML 的仿真器,该模型包含 23 个未知的自然史输入参数,以复制美国的 CRC 流行病学。我们首先生成 15000 个输入组合,并运行 CRC-AIM 模型来评估 CRC 发病率、腺瘤大小分布以及结肠镜检查检测到的小腺瘤比例。然后,我们使用这个数据集来训练几种 ML 算法,包括深度神经网络(DNN)、随机森林和几种梯度提升变体(即 XGBoost、LightGBM、CatBoost),并比较它们的性能。我们使用选定的仿真器评估了 1000 万个潜在的输入组合,并检查了最佳估计观察校准目标的输入组合。此外,我们还使用 CISNET 模型对 CRC-AIM 模型生成的结果进行了交叉验证。使用英国 Flexile Sigmoidoscopy Screening Trial (UKFSST) 对校准后的 CRC-AIM 模型进行了外部验证。

结果

经过适当预处理的 DNN 优于其他经过测试的 ML 算法,成功预测了不同输入组合的所有 8 种结果。训练好的 DNN 预测 1000 万个输入的结果需要 473 秒,而没有我们的 DNN 则需要 190 个 CPU 年。整个校准过程需要 104 个 CPU 天,包括构建数据集、训练、选择和调整 ML 算法的超参数。虽然有 7 个输入组合的拟合度可以接受,但选择一个最能拟合所有结果的组合作为最佳向量。最佳向量的几乎所有预测都在 CISNET 模型的预测范围内,表明 CRC-AIM 具有跨模型的有效性。同样,CRC-AIM 准确预测了 UKFSST 报告的 CRC 发病率和死亡率的风险比,表明其具有外部有效性。对校准目标的影响的检查表明,在基于筛查的预期寿命获益方面,校准目标的选择对模型结果具有实质性影响。

结论

经过精心选择和训练的仿真器(如 DNN)可以大大减少校准复杂微观模拟模型的计算负担。

重点

校准一个微观模拟模型,即找到不可观测参数的过程,以便模型与观察数据拟合,是一个计算复杂的过程。我们使用了一个深度神经网络模型,一种流行的机器学习算法,来校准 Colorectal Cancer Adenoma Incidence and Mortality (CRC-AIM) 模型。我们证明了我们的方法提供了一种高效准确的方法,可以显著加快微观模拟模型中的校准过程。校准过程成功地对 CRC-AIM 进行了跨 3 个已建立的 CISNET 模型的验证,并对随机对照试验进行了外部验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/d0158377719a/10.1177_0272989X231184175-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/7693353ed28a/10.1177_0272989X231184175-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/b4744cb65938/10.1177_0272989X231184175-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/4780954c7bbf/10.1177_0272989X231184175-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/8fceb5be1352/10.1177_0272989X231184175-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/4d3723fd0ff1/10.1177_0272989X231184175-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/98383634bb4f/10.1177_0272989X231184175-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/d0158377719a/10.1177_0272989X231184175-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/7693353ed28a/10.1177_0272989X231184175-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/b4744cb65938/10.1177_0272989X231184175-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/4780954c7bbf/10.1177_0272989X231184175-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/8fceb5be1352/10.1177_0272989X231184175-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/4d3723fd0ff1/10.1177_0272989X231184175-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/98383634bb4f/10.1177_0272989X231184175-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b936/10422851/d0158377719a/10.1177_0272989X231184175-fig7.jpg

相似文献

1
Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks.基于深度神经网络的结直肠癌与腺瘤发病和死亡(CRC-AIM)微观模拟模型的校准和验证。
Med Decis Making. 2023 Aug;43(6):719-736. doi: 10.1177/0272989X231184175. Epub 2023 Jul 11.
2
Emulator-Based Bayesian Calibration of the CISNET Colorectal Cancer Models.基于仿真器的 CISNET 结直肠癌模型的贝叶斯校准。
Med Decis Making. 2024 Jul;44(5):543-553. doi: 10.1177/0272989X241255618. Epub 2024 Jun 10.
3
Emulator-based Bayesian calibration of the CISNET colorectal cancer models.基于模拟器的CISNET结直肠癌模型的贝叶斯校准
medRxiv. 2024 Feb 5:2023.02.27.23286525. doi: 10.1101/2023.02.27.23286525.
4
Modeling the Natural History and Screening Effects of Colorectal Cancer Using Both Adenoma and Serrated Neoplasia Pathways: The Development, Calibration, and Validation of a Discrete Event Simulation Model.利用腺瘤和锯齿状肿瘤形成途径对结直肠癌的自然史和筛查效果进行建模:一个离散事件模拟模型的开发、校准与验证
MDM Policy Pract. 2023 Jan 19;8(1):23814683221145701. doi: 10.1177/23814683221145701. eCollection 2023 Jan-Jun.
5
Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application.中国结直肠癌预防与干预微模拟模型(MIMIC-CRC):开发、校准、验证与应用
Front Oncol. 2022 Apr 22;12:883401. doi: 10.3389/fonc.2022.883401. eCollection 2022.
6
An evidence-based microsimulation model for colorectal cancer: validation and application.基于证据的结直肠癌微观模拟模型:验证与应用。
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1992-2002. doi: 10.1158/1055-9965.EPI-09-0954. Epub 2010 Jul 20.
7
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.用于指导结直肠癌筛查指南的模型验证:准确性及影响
Med Decis Making. 2016 Jul;36(5):604-14. doi: 10.1177/0272989X15622642. Epub 2016 Jan 8.
8
Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.结直肠癌筛查中的建模:使用 NORCCAP 试验结果评估 MISCAN-Colon 微观模拟模型的外部和预测有效性。
Med Decis Making. 2018 Nov;38(8):917-929. doi: 10.1177/0272989X18806497. Epub 2018 Oct 20.
9
Validation of Colorectal Cancer Models on Long-term Outcomes from a Randomized Controlled Trial.验证结直肠癌模型对随机对照试验长期结局的预测价值。
Med Decis Making. 2020 Nov;40(8):1034-1040. doi: 10.1177/0272989X20961095. Epub 2020 Oct 20.
10
Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials.验证针对替代模型预测和随机对照试验长期结直肠癌发病率和死亡率结局的微观模拟模型。
Med Decis Making. 2020 Aug;40(6):815-829. doi: 10.1177/0272989X20944869.

引用本文的文献

1
Discrete-Event Simulation Model for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.用于R语言中癌症干预与人群健康的离散事件模拟模型(DESCIPHR):一种开源流程
medRxiv. 2025 May 13:2025.05.12.25327470. doi: 10.1101/2025.05.12.25327470.
2
Calculating epidemiological outcomes from simulated longitudinal data.从模拟纵向数据计算流行病学结果。
medRxiv. 2025 May 2:2025.04.30.25326766. doi: 10.1101/2025.04.30.25326766.
3
Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations.

本文引用的文献

1
Cost-Effectiveness and Value-of-Information Analysis Using Machine Learning-Based Metamodeling: A Case of Hepatitis C Treatment.使用基于机器学习的元建模进行成本效益和信息价值分析:以丙型肝炎治疗为例
Med Decis Making. 2023 Jan;43(1):68-77. doi: 10.1177/0272989X221125418. Epub 2022 Sep 16.
2
Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application.中国结直肠癌预防与干预微模拟模型(MIMIC-CRC):开发、校准、验证与应用
Front Oncol. 2022 Apr 22;12:883401. doi: 10.3389/fonc.2022.883401. eCollection 2022.
3
Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study.
通过将疾病停留密度计算为偏微分方程来评估半马尔可夫过程和其他流行病学事件发生时间模型。
Med Decis Making. 2025 Jul;45(5):569-586. doi: 10.1177/0272989X251333398. Epub 2025 May 8.
4
Environmental impact of colorectal cancer screening with colonoscopy and multi-target stool DNA (mt-sDNA) testing.结肠镜检查和多靶点粪便DNA(mt-sDNA)检测用于结直肠癌筛查的环境影响
Health Aff Sch. 2025 Feb 28;3(3):qxaf041. doi: 10.1093/haschl/qxaf041. eCollection 2025 Mar.
5
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.种族差异对结肠镜检查随访和质量对结直肠癌结果的影响。
J Natl Cancer Inst. 2024 Nov 1;116(11):1807-1816. doi: 10.1093/jnci/djae140.
6
Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.结肠镜筛查时间表的最佳时机取决于腺瘤的检出率、腺瘤的风险、筛查的依从性和筛查的目标:一项微观模拟研究。
PLoS One. 2024 May 24;19(5):e0304374. doi: 10.1371/journal.pone.0304374. eCollection 2024.
7
Modeling Thyroid Cancer Epidemiology in the United States Using Papillary Thyroid Carcinoma Microsimulation Model.应用甲状腺乳头状癌微模拟模型对美国甲状腺癌流行病学进行建模。
Value Health. 2024 Mar;27(3):367-375. doi: 10.1016/j.jval.2023.12.007. Epub 2023 Dec 22.
8
A Call to Action to Increase Uptake of Follow-Up Colonoscopy After Initial Positive Stool-Based Colorectal Cancer Screening.呼吁采取行动提高初次粪便基结直肠癌筛查呈阳性后后续结肠镜检查的接受率。
Popul Health Manag. 2023 Dec;26(6):448-450. doi: 10.1089/pop.2023.0199. Epub 2023 Nov 7.
9
Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test.消除 Medicare 受益人的后续结肠镜检查费用分担对阳性粪便结直肠癌筛查试验后的影响。
Cancer Res Commun. 2023 Oct 17;3(10):2113-2117. doi: 10.1158/2767-9764.CRC-23-0322.
10
Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test.与基于粪便的结直肠癌筛查试验呈阳性后进行随访结肠镜检查相比,筛查结肠镜检查所获得的生命年数。
Prev Med Rep. 2022 Jan 19;26:101701. doi: 10.1016/j.pmedr.2022.101701. eCollection 2022 Apr.
人工智能用于结肠镜筛查的成本效益:建模研究。
Lancet Digit Health. 2022 Jun;4(6):e436-e444. doi: 10.1016/S2589-7500(22)00042-5. Epub 2022 Apr 13.
4
Microsimulation Model Calibration with Approximate Bayesian Computation in R: A Tutorial.使用 R 中的近似贝叶斯计算进行微观模拟模型校准:教程。
Med Decis Making. 2022 Jul;42(5):557-570. doi: 10.1177/0272989X221085569. Epub 2022 Mar 21.
5
Sequentially calibrating a Bayesian microsimulation model to incorporate new information and assumptions.按顺序校准贝叶斯微模拟模型,以纳入新信息和假设。
BMC Med Inform Decis Mak. 2022 Jan 12;22(1):12. doi: 10.1186/s12911-021-01726-0.
6
Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions.在存在数据不兼容的情况下校准癌症模型的自然史:问题与解决方案。
Pharmacoeconomics. 2022 Apr;40(4):359-366. doi: 10.1007/s40273-021-01125-3. Epub 2022 Jan 7.
7
Emulator-based Bayesian optimization for efficient multi-objective calibration of an individual-based model of malaria.基于仿真器的贝叶斯优化在疟疾个体模型的高效多目标校准中的应用。
Nat Commun. 2021 Dec 10;12(1):7212. doi: 10.1038/s41467-021-27486-z.
8
MICROSIMULATION MODEL CALIBRATION USING INCREMENTAL MIXTURE APPROXIMATE BAYESIAN COMPUTATION.使用增量混合近似贝叶斯计算的微观模拟模型校准
Ann Appl Stat. 2019 Dec;13(4):2189-2212. doi: 10.1214/19-aoas1279. Epub 2019 Nov 28.
9
BayCANN: Streamlining Bayesian Calibration With Artificial Neural Network Metamodeling.BayCANN:使用人工神经网络元建模简化贝叶斯校准
Front Physiol. 2021 May 25;12:662314. doi: 10.3389/fphys.2021.662314. eCollection 2021.
10
Choosing a Metamodel of a Simulation Model for Uncertainty Quantification.选择仿真模型不确定性量化的代理模型。
Med Decis Making. 2022 Jan;42(1):28-42. doi: 10.1177/0272989X211016307. Epub 2021 Jun 8.